Decipher Labs P/E Ratio
Decipher Labs P/E ratio. Decipher Labs (DECIPHER) P/E ratio is not applicable — EPS (TTM) ₹-3.05, 2 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 2 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 2
Current EPS: ₹-3.05
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.35 | 0 | Loss |
| Jun 2026 | -2.16 | -2 | Loss |
| Sept 2025 | 0.02 | 0 | Profit |
| Mar 2025 | -4.07 | -4 | Loss |
| Jun 2025 | -3.39 | -3 | Loss |
| Dec 2025 | -0.53 | -1 | Loss |
| Sept 2024 | -1.31 | -1 | Loss |
| Mar 2024 | 1.19 | 1 | Profit |
Healthcare Peers with Valid P/E Ratios — DECIPHER Comparison
Healthcare sector average P/E 54.57, median 32.11 — DECIPHER excluded (negative EPS).
Sector Average PE
54.57
Sector Median PE
32.11
Lowest PE
1.9
Profitable Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.9 | ₹60 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.33 | ₹55 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.8 | ₹5,998 | Low |
| Dipna Pharmachem | DPL | 4.34 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 5.24 | ₹71 | Low |
| Kabra Drugs | KABRADG | 5.47 | ₹41 | Low |
| GKB Ophthalmics | GKB | 5.56 | ₹30 | Low |
| Royal Sense | ROYAL | 5.61 | ₹37 | Low |
| Colinz Laboratories | COLINZ | 6.31 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Decipher Labs share price screener.
- Examine DECIPHER Q4 results for recent quarterly revenue, profit and EPS trends.
- Also explore DECIPHER share price data to track price trends across different timeframes.